ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 33 filers reported holding ETON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $529,650 | -36.8% | 160,988 | -27.9% | 0.00% | – |
| Q1 2024 | $837,821 | +505.3% | 223,419 | +607.0% | 0.00% | – |
| Q4 2023 | $138,408 | +48.8% | 31,600 | +41.7% | 0.00% | – |
| Q3 2023 | $92,991 | +120.3% | 22,300 | +103.4% | 0.00% | – |
| Q1 2023 | $42,211 | -46.0% | 10,964 | -60.7% | 0.00% | – |
| Q4 2022 | $78,120 | -75.6% | 27,900 | -81.7% | 0.00% | – |
| Q3 2022 | $320,000 | +85.0% | 152,480 | +131.0% | 0.00% | – |
| Q2 2022 | $173,000 | -58.8% | 66,000 | -31.5% | 0.00% | – |
| Q1 2022 | $420,000 | -18.0% | 96,400 | -19.5% | 0.00% | – |
| Q4 2021 | $512,000 | -50.0% | 119,786 | -41.0% | 0.00% | – |
| Q3 2021 | $1,023,000 | +47.2% | 202,993 | +80.1% | 0.00% | – |
| Q2 2021 | $695,000 | +852.1% | 112,700 | +1027.0% | 0.00% | – |
| Q1 2021 | $73,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,088,100 | $15,564,000 | 2.91% |
| AWM Investment Company, Inc. | 500,000 | $2,520,000 | 0.25% |
| HighVista Strategies LLC | 21,517 | $109,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 82,314 | $415,000 | 0.04% |
| XTX Topco Ltd | 14,652 | $74,000 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $84,000 | 0.02% |
| Financial Advisors Network, Inc. | 10,633 | $53,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,500 | $507,000 | 0.01% |
| Westside Investment Management, Inc. | 105,300 | $3,048,000 | 0.01% |
| Belvedere Trading LLC | 20,829 | $107,000 | 0.00% |